INTERLEUKIN-5 ENHANCES THE INVITRO ADHESION OF HUMAN EOSINOPHILS, BUT NOT NEUTROPHILS, IN A LEUKOCYTE INTEGRIN (CD11/18)-DEPENDENT MANNER

Garry Michael Walsh, A J WARDLAW, A HARTNELL, C J SANDERSON, A B KAY

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Interleukin (IL-5) was found to enhance the adhesion of eosinophils, but not neutrophils, to both microvascular and large vein endothelial cells in a dose-dependent manner. Granulocyte/macrophage-colony-stimulating factor (GM-CSF) and platelet-activating factor (PAF) enhanced both eosinophil and neutrophil adhesion. Significant increases in eosinophil CR3 expression, but not LFA-1, were observed following pre-incubation with PAF, IL-3, IL-5 or GM-CSF. Neutrophil CR3 expression was increased significantly by pre-incubation with PAF or GM-CSF, but not IL-3 or IL-5. Enhanced adhesion to human microvascular endothelial cells (HMVEC) or human umbilical vein endothelial cells (HUVEC) was inhibited by (ranked in order of potency) anti-CR3-alpha = common beta-chain > LFA-1-alpha. Anti-p150,95-alpha had no measurable effect. Basal expression of eosinophil CR3 with monoclonal antibody inhibited IL-5-induced eosinophil hyperadherence to HUVEC in a manner almost identical to inhibition in the presence of excess anti-CR3. Thus, a conformational or affintiy change in adhesion receptors following activation seems more important than a simple increase in numbers. No inhibition of unstimulated eosinophil adhesion to HMVEC or HUVEC by CD11/18 monoclonal antibody was observed. These findings demonstrate that IL-5 enhances eosinophil, but not neutrophil, adherence reactions, by a mechanism dependent, at least in part, on the CD11/18 family of adhesion glycoproteins.

Original languageEnglish
Pages (from-to)174-178
Number of pages5
JournalInternational Archives of Allergy and Applied Immunology
Volume94
Issue number1-4
Publication statusPublished - 1991

Keywords

  • PLATELET-ACTIVATING FACTOR
  • VASCULAR ENDOTHELIAL-CELLS
  • EXPRESSION
  • LEUKOCYTE
  • ADHERENCE
  • ICAM-1
  • LFA-1
  • RECEPTORS
  • P150,95
  • TISSUE

Cite this

INTERLEUKIN-5 ENHANCES THE INVITRO ADHESION OF HUMAN EOSINOPHILS, BUT NOT NEUTROPHILS, IN A LEUKOCYTE INTEGRIN (CD11/18)-DEPENDENT MANNER. / Walsh, Garry Michael; WARDLAW, A J ; HARTNELL, A ; SANDERSON, C J ; KAY, A B .

In: International Archives of Allergy and Applied Immunology, Vol. 94, No. 1-4, 1991, p. 174-178.

Research output: Contribution to journalArticle

@article{6f9377846fce44548c0a8a423f5db71e,
title = "INTERLEUKIN-5 ENHANCES THE INVITRO ADHESION OF HUMAN EOSINOPHILS, BUT NOT NEUTROPHILS, IN A LEUKOCYTE INTEGRIN (CD11/18)-DEPENDENT MANNER",
abstract = "Interleukin (IL-5) was found to enhance the adhesion of eosinophils, but not neutrophils, to both microvascular and large vein endothelial cells in a dose-dependent manner. Granulocyte/macrophage-colony-stimulating factor (GM-CSF) and platelet-activating factor (PAF) enhanced both eosinophil and neutrophil adhesion. Significant increases in eosinophil CR3 expression, but not LFA-1, were observed following pre-incubation with PAF, IL-3, IL-5 or GM-CSF. Neutrophil CR3 expression was increased significantly by pre-incubation with PAF or GM-CSF, but not IL-3 or IL-5. Enhanced adhesion to human microvascular endothelial cells (HMVEC) or human umbilical vein endothelial cells (HUVEC) was inhibited by (ranked in order of potency) anti-CR3-alpha = common beta-chain > LFA-1-alpha. Anti-p150,95-alpha had no measurable effect. Basal expression of eosinophil CR3 with monoclonal antibody inhibited IL-5-induced eosinophil hyperadherence to HUVEC in a manner almost identical to inhibition in the presence of excess anti-CR3. Thus, a conformational or affintiy change in adhesion receptors following activation seems more important than a simple increase in numbers. No inhibition of unstimulated eosinophil adhesion to HMVEC or HUVEC by CD11/18 monoclonal antibody was observed. These findings demonstrate that IL-5 enhances eosinophil, but not neutrophil, adherence reactions, by a mechanism dependent, at least in part, on the CD11/18 family of adhesion glycoproteins.",
keywords = "PLATELET-ACTIVATING FACTOR, VASCULAR ENDOTHELIAL-CELLS, EXPRESSION, LEUKOCYTE, ADHERENCE, ICAM-1, LFA-1, RECEPTORS, P150,95, TISSUE",
author = "Walsh, {Garry Michael} and WARDLAW, {A J} and A HARTNELL and SANDERSON, {C J} and KAY, {A B}",
year = "1991",
language = "English",
volume = "94",
pages = "174--178",
journal = "International Archives of Allergy and Applied Immunology",
issn = "0020-5915",
publisher = "S. Karger AG",
number = "1-4",

}

TY - JOUR

T1 - INTERLEUKIN-5 ENHANCES THE INVITRO ADHESION OF HUMAN EOSINOPHILS, BUT NOT NEUTROPHILS, IN A LEUKOCYTE INTEGRIN (CD11/18)-DEPENDENT MANNER

AU - Walsh, Garry Michael

AU - WARDLAW, A J

AU - HARTNELL, A

AU - SANDERSON, C J

AU - KAY, A B

PY - 1991

Y1 - 1991

N2 - Interleukin (IL-5) was found to enhance the adhesion of eosinophils, but not neutrophils, to both microvascular and large vein endothelial cells in a dose-dependent manner. Granulocyte/macrophage-colony-stimulating factor (GM-CSF) and platelet-activating factor (PAF) enhanced both eosinophil and neutrophil adhesion. Significant increases in eosinophil CR3 expression, but not LFA-1, were observed following pre-incubation with PAF, IL-3, IL-5 or GM-CSF. Neutrophil CR3 expression was increased significantly by pre-incubation with PAF or GM-CSF, but not IL-3 or IL-5. Enhanced adhesion to human microvascular endothelial cells (HMVEC) or human umbilical vein endothelial cells (HUVEC) was inhibited by (ranked in order of potency) anti-CR3-alpha = common beta-chain > LFA-1-alpha. Anti-p150,95-alpha had no measurable effect. Basal expression of eosinophil CR3 with monoclonal antibody inhibited IL-5-induced eosinophil hyperadherence to HUVEC in a manner almost identical to inhibition in the presence of excess anti-CR3. Thus, a conformational or affintiy change in adhesion receptors following activation seems more important than a simple increase in numbers. No inhibition of unstimulated eosinophil adhesion to HMVEC or HUVEC by CD11/18 monoclonal antibody was observed. These findings demonstrate that IL-5 enhances eosinophil, but not neutrophil, adherence reactions, by a mechanism dependent, at least in part, on the CD11/18 family of adhesion glycoproteins.

AB - Interleukin (IL-5) was found to enhance the adhesion of eosinophils, but not neutrophils, to both microvascular and large vein endothelial cells in a dose-dependent manner. Granulocyte/macrophage-colony-stimulating factor (GM-CSF) and platelet-activating factor (PAF) enhanced both eosinophil and neutrophil adhesion. Significant increases in eosinophil CR3 expression, but not LFA-1, were observed following pre-incubation with PAF, IL-3, IL-5 or GM-CSF. Neutrophil CR3 expression was increased significantly by pre-incubation with PAF or GM-CSF, but not IL-3 or IL-5. Enhanced adhesion to human microvascular endothelial cells (HMVEC) or human umbilical vein endothelial cells (HUVEC) was inhibited by (ranked in order of potency) anti-CR3-alpha = common beta-chain > LFA-1-alpha. Anti-p150,95-alpha had no measurable effect. Basal expression of eosinophil CR3 with monoclonal antibody inhibited IL-5-induced eosinophil hyperadherence to HUVEC in a manner almost identical to inhibition in the presence of excess anti-CR3. Thus, a conformational or affintiy change in adhesion receptors following activation seems more important than a simple increase in numbers. No inhibition of unstimulated eosinophil adhesion to HMVEC or HUVEC by CD11/18 monoclonal antibody was observed. These findings demonstrate that IL-5 enhances eosinophil, but not neutrophil, adherence reactions, by a mechanism dependent, at least in part, on the CD11/18 family of adhesion glycoproteins.

KW - PLATELET-ACTIVATING FACTOR

KW - VASCULAR ENDOTHELIAL-CELLS

KW - EXPRESSION

KW - LEUKOCYTE

KW - ADHERENCE

KW - ICAM-1

KW - LFA-1

KW - RECEPTORS

KW - P150,95

KW - TISSUE

M3 - Article

VL - 94

SP - 174

EP - 178

JO - International Archives of Allergy and Applied Immunology

JF - International Archives of Allergy and Applied Immunology

SN - 0020-5915

IS - 1-4

ER -